T2	GGPs 857 906	interferon-inducible T cell alpha chemoattractant
T4	Anatomical_entity 578 582	BALF
T6	GGPs 451 460	chemokine
T7	Disorder 44 47	IPF
T11	Disorder 70 99	Extrinsic allergic alveolitis
T12	Disorder 689 692	IPF
T13	Disorder 1566 1569	EAA
T15	Disorder 674 677	EAA
T17	Disorder 1446 1449	EAA
T18	Disorder 1087 1090	IPF
T20	Pharmacological_substance 1642 1657	provoking agent
T21	GGPs 1580 1584	IL-8
T22	Anatomical_entity 1204 1208	BALF
T23	GGPs 523 542	chemokine receptors
T24	Disorder 52 55	EAA
T27	Disorder 1733 1736	IPF
T31	Disorder 141 144	IPF
T35	Disorder 1661 1664	EAA
T37	GGPs 1050 1059	chemokine
T40	Disorder 1430 1433	IPF
T43	Disorder 1177 1180	IPF
T44	GGPs 30 40	chemokines
T46	GGPs 547 550	CD4
T48	GGPs 568 573	CXCR3
T51	Anatomical_entity 1045 1049	BALF
T52	GGPs 1676 1680	IL-8
T53	Anatomical_entity 918 922	BALF
T54	GGPs 759 799;805 808	epithelial neutrophil activating protein -78
T61	GGPs 561 566	CXCR2
T62	GGPs 1481 1487	ENA-78
T64	Disorder 110 139	idiopathic pulmonary fibrosis
T65	Disorder 1169 1172	EAA
T68	Disorder 1543 1558	lung impairment
T70	Disorder 607 615	diseases
T74	Anatomical_entity 222 230	Vascular
T76	Disorder 1346 1360	disease course
T77	GGPs 1380 1384	IL-8
T79	Subject 1570 1578	patients
T80	Disorder 101 104	EAA
T82	GGPs 801 804;805 808	ENA -78
T83	Anatomical_entity 502 506	BALF
T84	GGPs 752 754;755 757	IL -8
T87	Anatomical_entity 472 500	bronchoalveolar lavage fluid
T91	Disorder 1079 1082	EAA
T93	GGPs 1389 1395	ENA-78
T96	Cell 552 559	T cells
T104	GGPs 739 750;755 757	interleukin -8
T107	Subject 1665 1673	patients
T109	Anatomical_entity 1103 1107	BALF
T115	GGPs 1098 1102	IL-8
N15	Reference T4 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N21	Reference T6 UMLS:C0282554	chemokine
N23	Reference T7 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N31	Reference T11 UMLS:C0002390	Extrinsic allergic alveolitis
N34	Reference T12 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N52	Reference T18 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N64	Reference T21 UMLS:C1698756	CXCL8 protein, human
N65	Reference T22 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N69	Reference T23 UMLS:C0524914	chemokine receptor
N77	Reference T27 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N93	Reference T31 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N113	Reference T37 UMLS:C0282554	chemokine
N123	Reference T40 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N132	Reference T43 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N136	Reference T44 UMLS:C0282554	chemokine
N142	Reference T46 UMLS:C4048280	T-Cell Surface Glycoprotein CD4, human
N150	Reference T48 UMLS:C1741914	CXCR3 protein, human
N160	Reference T51 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N164	Reference T52 UMLS:C1698756	CXCL8 protein, human
N165	Reference T53 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N197	Reference T64 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N223	Reference T70 UMLS:C0012634	Disease
N234	Reference T74 UMLS:C0005847	Blood Vessel
N242	Reference T76 UMLS:C0242656	Disease Progression
N245	Reference T77 UMLS:C1698756	CXCL8 protein, human
N248	Reference T79 UMLS:C0030705	Patients
N258	Reference T83 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N273	Reference T87 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N305	Reference T96 UMLS:C0039194	T-Lymphocyte
N341	Reference T107 UMLS:C0030705	Patients
N348	Reference T109 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N375	Reference T115 UMLS:C1698756	CXCL8 protein, human
E12	Cellular_process:T34 disorder:T7 Participant:T44
T118	Biological_process 19 29	angiogenic
E13	Biological_process:T118 disorder:T7 Participant:T44
N1	Reference E13 UMLS:C0302600	Angiogenic Process
N3	Reference E12 UMLS:C1510884	Angiogenesis Inhibition
T10	Disorder 222 238	Vascular changes
T14	Correlation 262 271	accompany
E1	Correlation:T14 Theme:T10 Theme2:E2
T26	Biological_process 276 299	development of fibrosis
E2	Biological_process:T26 
T32	Disorder 420 428	diseases
T58	GGPs 395 404	chemokine
T63	Cellular_process 368 379	angiostatic
E14	Cellular_process:T63 Participant:T58 disorder:T11
T19	Biological_process 384 394	angiogenic
E15	Biological_process:T19 Participant:T58 disorder:T64
N11	Reference E15 UMLS:C0302600	Angiogenic Process
T69	Gene_expression 462 468	levels
E16	Gene_expression:T69 Theme:T6 atLoc:T87 disorder:T70
N12	Reference E16 UMLS:C0017262	Gene Expression
T75	Entity_Property 550 551	+
T81	Cell 547 559	CD4+ T cells
R6	member_of Arg1:T81 Arg2:T96	
T95	Gene_expression 509 519	expression
E17	Gene_expression:T95 Theme:T61 atLoc:T81 disorder:T70
N13	Reference E17 UMLS:C0017262	Gene Expression
R7	part_of Arg1:T81 Arg2:T4	
R8	member_of Arg1:T61 Arg2:T23	
R9	member_of Arg1:T48 Arg2:T23	
E9	Gene_expression:T95 Theme:T48 atLoc:T81 disorder:T70
N14	Reference E9 UMLS:C0017262	Gene Expression
T25	Subject 644 660	Sixteen patients
A1	Count_sbjct T25
A2	Organism_sbjct T25 Human
A3	Patient_sbjct T25 Patient
T119	Subject 682 683	8
A4	Count_sbjct T119
A5	Organism_sbjct T119 Human
A6	Patient_sbjct T119 Patient
R10	Subject_Disorder Arg1:T25 Arg2:T15	
R11	Subject_Disorder Arg1:T119 Arg2:T12	
T1	GGPs 810 844;849 852	interferon-gamma-inducible protein -10
T57	GGPs 846 848;849 852	IP -10
N2	Reference T1 UMLS:C1308752	CXCL10 protein, human
T47	GGPs 908 913	I-TAC
T85	Method_cue 958 991	Fluorokine MultiAnalyte profiling
T50	Gene_expression 1060 1066	levels
E8	Gene_expression:T50 Theme:T37 atLoc:T51 disorder:T18
N5	Reference E8 UMLS:C0017262	Gene Expression
T86	Subject 1079 1082;1091 1096	EAA group
T88	Subject 1087 1090;1091 1096	IPF group
E10	Gene_expression:T50 Theme:T37 atLoc:T51 disorder:T91
N7	Reference E10 UMLS:C0017262	Gene Expression
T92	Biological_process 1152 1160	fibrosis
E20	Biological_process:T92 disorder:T65 atLoc:T109
E23	Biological_process:T92 disorder:T43 atLoc:T109
T94	Negation_cue 1227 1230	not
N19	Reference T94 UMLS:C1518422	Negation
T9	GGPs 1198 1203	IP-10
T16	Method_cue 1257 1261	HRCT
T38	Regulation 1405 1411;1422 1426	play a role
E3	Regulation:T38 Cause:T77 Theme:E25
T39	Regulation 1405 1411;1422 1426	play a role
E5	Regulation:T39 Cause:T93 Theme:E24
T49	Biological_process 1450 1462	pathogenesis
E24	Biological_process:T49 Theme:T40
E25	Biological_process:T49 Theme:T17
N18	Reference T68 UMLS:C1709770	Pulmonary Dysfunction
R16	Subject_Disorder Arg1:T79 Arg2:T13	
R17	Subject_Disorder Arg1:T107 Arg2:T35	
N22	Reference T80 UMLS:C0002390	Extrinsic allergic alveolitis
N29	Reference T24 UMLS:C0002390	Extrinsic allergic alveolitis
N30	Reference T15 UMLS:C0002390	Extrinsic allergic alveolitis
N32	Reference T91 UMLS:C0002390	Extrinsic allergic alveolitis
N33	Reference T65 UMLS:C0002390	Extrinsic allergic alveolitis
N35	Reference T17 UMLS:C0002390	Extrinsic allergic alveolitis
N36	Reference T13 UMLS:C0002390	Extrinsic allergic alveolitis
N37	Reference T35 UMLS:C0002390	Extrinsic allergic alveolitis
N38	Reference E14 UMLS:C1510884	Angiogenesis Inhibition
N39	Reference T58 UMLS:C0282554	chemokine
N40	Reference T75 UMLS:C1446409	Positive
N41	Reference T61 UMLS:C4082290	C-X-C Chemokine Receptor Type 2, human
N44	Reference T104 UMLS:C1698756	CXCL8 protein, human
N45	Reference T84 UMLS:C1698756	CXCL8 protein, human
N46	Reference T54 UMLS:C1435946	CXCL5 protein, human
N47	Reference T82 UMLS:C1435946	CXCL5 protein, human
N48	Reference T57 UMLS:C1308752	CXCL10 protein, human
N4	Reference T2 UMLS:C0676150	Chemokine CXCL11
N49	Reference T47 UMLS:C0676150	Chemokine CXCL11
R18	Subject_Disorder Arg1:T88 Arg2:T18	
R19	Subject_Disorder Arg1:T86 Arg2:T91	
N50	Reference T9 UMLS:C1308752	CXCL10 protein, human
N51	Reference T93 UMLS:C1435946	CXCL5 protein, human
N54	Reference T62 UMLS:C1435946	CXCL5 protein, human
E27	Biological_process:T118 disorder:T24 Participant:T44
N55	Reference E27 UMLS:C0302600	Angiogenic Process
E28	Cellular_process:T34 disorder:T24 Participant:T44
N28	Reference E28 UMLS:C1510884	Angiogenesis Inhibition
T34	Cellular_process 0 11	Angiostatic
N6	Reference T10 UMLS:C1336951	Vascular Morphologic Change
T33	Method_cue 587 599	HRCT pattern
N10	Reference T33 UMLS:C1512457	High Resolution Computed Tomography
A19	Speculated E9
A21	Speculated E17
A23	Speculated E16
A25	Organism_sbjct T88 Human
A26	Patient_sbjct T88 Patient
A27	Organism_sbjct T86 Human
A28	Patient_sbjct T86 Patient
N9	Reference T16 UMLS:C1512457	High Resolution Computed Tomography
A30	Organism_sbjct T79 Human
A31	Patient_sbjct T79 Patient
A11	Organism_sbjct T107 Human
A12	Patient_sbjct T107 Patient
R21	Disorder_association Arg1:T13 Arg2:T68	
N17	Reference E23 UMLS:C0016059	Fibrosis
N24	Reference E20 UMLS:C0016059	Fibrosis
N26	Reference E5 UMLS:C1327622	Regulation of biological process
N27	Reference E3 UMLS:C1327622	Regulation of biological process
N57	Reference E25 UMLS:C0699748	Pathogenesis
N58	Reference E24 UMLS:C0699748	Pathogenesis
N25	Reference T20 UMLS:C3898767	Inducer
N8	Reference E2 UMLS:C0596570	fibrogenesis
T72	Artificial_process 1108 1122	concentrations
E19	Artificial_process:T72 Instrument:T115 Theme:T109
T73	Artificial_process 1209 1223	concentrations
E26	Artificial_process:T73 Instrument:T9 Theme:T22
N63	Reference E26 UMLS:C2003864	Concentrate (activity)
N66	Reference E19 UMLS:C2003864	Concentrate (activity)
T78	Measurement 1274 1292	interstitial score
T90	Measurement 1257 1270;1287 1292	HRCT alveolar score
T97	Correlation 1324 1336	relationship
E29	Correlation:T97 Theme:T9 Theme2:T76
N16	Reference E1 UMLS:C0332281	Associated with
T98	Correlation 430 442	Correlations
E31	Correlation:T98 Theme:E16 Theme2:E9 Theme3:E17 Theme4:T70
N67	Reference E31 UMLS:C0332281	Associated with
T5	Correlation 1123 1132	correlate
E32	Correlation:T5 Theme:T115 Theme2:E23 Theme3:E20
N68	Reference E32 UMLS:C0332281	Associated with
T60	Correlation 1231 1240	correlate
E21	Correlation:T60 Theme:T9 Theme2:T90 Theme3:T78 Cue:T94
N43	Reference E21 UMLS:C0332281	Associated with
A16	Negated E21
N42	Reference E29 UMLS:C0332281	Associated with
T28	Artificial_process 1687 1692	serve
E11	Artificial_process:T28 Instrument:T52 Theme:T27
N53	Reference E11 UMLS:C0087111	Therapeutic procedure
T8	Correlation 146 151	share
E22	Correlation:T8 Theme:T11 Theme2:T64 Theme3:T29
N20	Reference E22 UMLS:C0332281	Associated with
T29	Disorder 183 220	interstitial involvement and fibrosis
N70	Reference T29 UMLS:C0240035	Interstitial fibrosis
T3	Entity_Property 666 673	chronic
T30	Gene_expression 721 735	Concentrations
E30	Gene_expression:T30 Cue:T85 Theme:T1 atLoc:T53
N56	Reference E30 UMLS:C0017262	Gene Expression
E33	Gene_expression:T30 Cue:T85 Theme:T2 atLoc:T53
N71	Reference E33 UMLS:C0017262	Gene Expression
E34	Gene_expression:T30 Cue:T85 Theme:T54 atLoc:T53
N72	Reference E34 UMLS:C0017262	Gene Expression
E35	Gene_expression:T30 Cue:T85 Theme:T104 atLoc:T53
N73	Reference E35 UMLS:C0017262	Gene Expression
T36	Entity_Property 1438 1445	chronic
N59	Reference T36 UMLS:C0205191	chronic
N60	Reference T3 UMLS:C0205191	chronic
T41	GGPs 1708 1714	marker
N61	Reference T41 UMLS:C0005516	Biological Markers
R1	member_of Arg1:T52 Arg2:T41	
T42	GGPs 1495 1501	marker
N62	Reference T42 UMLS:C0005516	Biological Markers
R2	member_of Arg1:T62 Arg2:T42	
T45	GGPs 1604 1613	indicator
N74	Reference T45 UMLS:C0005516	Biological Markers
R3	member_of Arg1:T21 Arg2:T45	
N75	Reference T25 UMLS:C0030705	Patients
N76	Reference T119 UMLS:C0030705	Patients
N78	Reference T86 UMLS:C0030705	Patients
N79	Reference T88 UMLS:C0030705	Patients
